Role of infectious agents in autoimmunity

Future Rheumatology

Volumn 2, Issue 3, 2007, Pages 321-328

  Navarra, Sandra V ^a  

^a UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; BACTERIAL ANTIGEN; HLA B27 ANTIGEN; HLA DR ANTIGEN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; LAMIVUDINE; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE BINDING LECTIN; PHOSPHOLIPID ANTIBODY; RIBAVIRIN; STEROID; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

ANTIPHOSPHOLIPID SYNDROME; AORTA ARCH SYNDROME; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BORRELIA BURGDORFERI; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; CRYOGLOBULINEMIA; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; LYME DISEASE; LYMPHOPROLIFERATIVE DISEASE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA; MYCOPLASMA PULMONIS; NATURAL KILLER CELL; NEISSERIA; PARVOVIRUS; PATHOPHYSIOLOGY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROTEUS MIRABILIS; RETROVIRUS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; YERSINIA ENTEROCOLITICA;

EID: 34347379285     PISSN: 17460816     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460816.2.3.321     Document Type: Review

References (94)

1. Rose NR: The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol. 10, 5-13 (1998).
2. Horwitz MS, Sarvetnick N: Viruses, host responses and autoimmunity. Immunol. Rev. 169, 241-253 (1999).
3. Panoutsakopoulou V, Cantor H: On the relationship between viral infection and autoimmunity. J. Autoimmunity 16, 341-345 (2001).
4. Navarra SV: Infectious agents in arthritis and autoimmunity. Mod. Rheumatol. 13, 97-102 (2003).
5. Fujinami RS: Viruses and autoimmune disease - two sides of the same coin? Trends Microbiol. 9, 377-381 (2001).
6. Shi FD, Ljunggren HG, Sarvetnick N: Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 22, 97-101 (2001).
7. Pacheco-Tena C, Zhang X, Stone M, Burgos-Vargas R, Inman RD: Innate immunity in host-microbial interactions: beyond B27 in the spondyloarthropathies. Curr. Opin. Rheumatol. 14, 373-382 (2002).
8. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR: From infection to autoimmunity. J. Autoimmunity 16, 175-186 (2001).
9. Fairweather D, Rose NR: Inflammatory heart disease: a role for cytokines. Lupus 14, 646-651 (2005).
10. Anders HJ, Zecher D, Pawar RD, Patole PS: Molecular mechanisms of autoimmunity triggered by microbial infection. Arthritis Res. Ther. 7, 215-224 (2005).
11. Ranjeny T: The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation. Arthritis Res. Ther. 7, 170-173 (2005).
12. Anders HJ, Vielhauer V, Eis V et al.: Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas (lpr) mice. FASEB J. 18, 534-536 (2004).
13. Albert LJ, Zhao Y-X, Inman RD: Molecular mimicry. In: Textbook of the Autoimmune Diseases. Lahita RG. Chiorazzi N, Reeves WH (Eds). Lippincott Williams & Wilkins, PA, USA, 153-174 (2000).
14. Gianani R, Sarvetnick N: Viruses, cytokines, antigens and autoimmunity. Proc. Natl Acad. Sci. USA, 93, 2257-2259 (1996).
15. Crow MK: Superantigens. In: Textbook of the Autoimmune Diseases. Lahita RG, Chiorazzi N, Reeves WH (Eds). Lippincott Williams and Wilkins, PA, USA 19-35 (2000).
16. Schiffenbauer J, Soos J, Johnson H: The possible rule of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol. Today 19, 117-120 (1998).
17. Sekigawa I, Ogasawara H, Kaneko H. Hishikawa T, Hashimoto H: Retroviruses and autoimmunity. Intern. Med. 40, 80-86 (2001).
18. Leib-Mosch C, Brack-Werner R, Werner T et al.: Endogenous retroviral elements in human DNA. Cancer Res. 50, S5636-S5642 (1993).
19. Adelman MK. Marchalonis JJ: Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin. Immunol. 102, 107-116 (2002).
20. Yu D, Kuipers JG: Role of bacteria and HLA-B27 in the pathogenesis of reactive arthritis. Rheum. Dis. Clin. N. Am. 29. 21-36 (2003).
21. Kohler L, Zeidler H, Hudson AP: Etiologic agents in reactive arthritis: their molecular biology and phagocyte-host interactions. Baillieres Clin. Rheumatol. 12, 589-609 (1998).
22. McGonagle D, Stockwin L. Isaacs J, Emery P: An enthesis-based model for the pathogenesis of spondyloarthropathy: additive effects of microbial adjuvant and biomechanical factors at disease sites. J. Rheumatol. 28, 2155-2159 (2001).
23. Vahamiko S. Penttinen MA, Granfors K: Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27. Arthritis Res. Ther. 7, 136-141 (2005).
24. Turner MJ, Colbert RA: HLA-B27 and pathogenesis of spondyloarthropathies. Curr. Opin. Rheumatol. 14, 367-372 (2002).
25. Pacheco-Tena C, Alvarado DLB, Lopez-Vidal Y et al.: Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology 40, 920-927 (2001).
26. Miossec P: Reactive arthritis associated with bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: Immune reactivity against mycobacterial antigens (Letter). J. Rheumatol. 23, 1485 (1996).
27. Buchs N, Chevrel G, Miossec P: Bacillus Calmette-Guerin induced aseptic arthritis: an experimental model of reactive arthritis. J. Rheumatol. 25, 1662-1665 (1998).
28. Steere AC: Lyme disease. N. Engl. J. Med. 345, 115-125 (2001).
29. Weyand CA, Goronzy JJ: Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis Rheum. 32, 1057-1064 (1989).
30. Guerao-de-Arellano M, Huber BT: Development of autoimmunity in Lyme arthritis. Curr. Opin. Rheumatol. 14, 388-393 (2002).
31. Weinstein A, Britchkov M: Lyme arthritis and post-Lyme disease syndrome. Curr. Opin. Rheumatol. 14, 383-387 (2002).
32. Ferrell PB, Aitcheson CT, Pearson GR, Tan EM: Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J. Clin. Invest. 67, 681-687 (1981).
33. Sculley TB, Walker PJ, Moss DJ, Pope JH: Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J. Virol. 52, 88-93 (1984).
34. Takeda T, Mizugaki Y, Matsubara L, Imai S, Kolke T, Takada K: Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 43, 1218-1225 (2000).
35. Blaschke S, Schwarz G, Moneke D, Binder L, Muller G, Reuss-Borst M: Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells and synovial membranes of patients with rheumatoid arthritis. J. Rheumatol. 27, 866-873 (2000).
36. Sawada S, Takei M: Epstein-Barr virus and rheumatoid arthritis (Letter). J. Rheumatol. 28, 2363 (2001).
37. Einseie H, Steidle M, Muller CA et al.: Demonstration of cytomegalovirus DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis. J. Rheumatol. 19. 677-681 (1992).
38. Tamm A, Ziegler T, Lautenschlager I et al.: Detection of cytomegalovirus DNA in cells from synovial fluid and peripheral blood of patients with early rheumatoid arthritis. J. Rheumatol. 20, 1489-1493 (1993).
39. Brand A, Griffiths DJ. Herve C et al.: Human retrovirus-5 in rheumatic disease. J. Autoimmunity 13, 149-154 (1999).
40. Martinelli M, Giozza SP, Novaes AE, Carvalho EM, Araujo IM: Rheumatic diseases in HTLV-1 infected individuals (Abstract). J. Clin. Rheumatol. 12, S7 (2006).
41. Zuckerman E, Keren D, Rozenbaum M: Hepatitis C virus related arthritis: characteristics and resonse to therapy with interferon α. Clin. Exp. Rheumatol. 18. 579-584 (2000).
42. Olivieri I, Palazzi C, Padula A: Hepatitis C virus and arthritis. Rheum. Dis. Clin. N. Am. 29, 111-122 (2003).
43. Gripenberg M: Common serological features in rheumatoid arthritis and Yersinia arthritis. Demonstration of rheumatoid factors and antibodies against DNA and Yersinia enterocolitica lipopolysaccharide by ELISA. Scand. J. Rheumatol. 10, 85-91 (1981).
44. Wilson C, Tiwana H. Ebringer A: Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the aetiological basis for autoimmunity. Microbes Infec. 2, 1489-1496 (2000).
45. Hsu HC, Zhang HG, Song GG et al.: Defective fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Arthritis Rheum. 44, 2146-2159 (2001).
46. Ebringer A, Wilson C, Tiwana H: Is rheumatoid arthritis a form of reactive arthritis? J. Rheumatol. 27, 559-562 (2000).
47. Albert LJ: Infection and rheumatoid arthritis: guilt by association? J. Rheumatol. 27, 564-566 (2000).
48. James JA, Harley JB. Scofield RH: Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr. Opin. Rheumatol. 13, 370-376 (2001).
49. Reveille JD: The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin. Arthritis Rheum. 30, 147-166 (2000).
50. Mongey A-B, Hess EV: The rule of environment in systemic lupus erythematosus and associated disorders. In: Dubois' Lupus Erythematosus (6th Edition). Wallace DJ, Hahn BH (Eds). Lippincott Williams & Wilkins, PA, USA 33-64 (2002).
51. Perl A: Role of endogenous retroviruses in autoimmune diseases. Rheum. Dis. Clin. N. Am. 29, 123-143 (2003).
52. James JA, Neas BR, Moser KL et al.: Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44, 1122-1126 (2001).
53. Fawaz-Estrup F: Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J. Rheumatol. 23, 1180-1185 (1996).
54. Moore TL, Bandlamudi R, Alam SM, Nesher G: Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin. Arthritis Rheum. 28, 314-318 (1999).
55. Kok W, Wolfhagen JHM, Klosters G: A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin. Infect. Dis. 32, 311-312 (2001).
56. Kalt M, Gertner E: Antibodies to β2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J. Rheumatol. 28, 2335-2336 (2001).
57. Kawashiri S-Y, Nakamura H, Kawakami A et al.: Emergence of Epstein-Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus. Lupus 15, 51-53 (2006).
58. Gergely P, Perl A, Poor G: Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases? Autoimmunity Rev. 6, 5-9 (2006).
59. Fox R, Isenberg DA: Human Immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum. 40, 1168-1172 (1997).
60. Palacios R, Santos J. Valdivielso P, Marquez M: Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of literature. Lupus 11, 60-63 (2002).
61. Gold J, Haubenstock A, Zalusky R: Lupus anticoagulant and AIDS. N. Engl. J. Med. 314, 1252-1253 (1986).
62. Stimmier M. Quismorio F, McGehee W et al.: Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch. Int. Med. 149, 1833-1835 (1989).
63. Savige JA, Chang L, Crowe SM: Antinuclear, antineutrophil cytoplasmic and antiglomerular basement membrane antibodies in HIV-infected individuals. Autoimnmunity 18, 205-211 (1994).
64. Perl A, Colombo E, Dai H et al.: Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Arthritis Rheum. 38, 1661-1672 (1995).
65. Magistrelli C, Samollova RK, Agarwal K et al.: Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 49, 829-834 (1999).
66. Gergely P, Pullmann R, Stancato C et al.: Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin. Immunol. 116, 124-134 (2005).
67. Ronnblom L, Alm GV: An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 22, 427-431 (2001).
68. Theofilopoulos AN, Baccala R, Beuder B, Kono DH: Type I interferons in immunity and autoimmunity. Annu. Rev Immunol. 23, 307-336 (2005).
69. Juarez M, Misischia R, Alarcon GS: Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum. Dis. Clin. N. Am. 29, 163-184 (2003).
70. Garred P, Voss A, Madsen HO et al.: Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2, 442-450 (2001).
71. Sturfelt G, Truedsson L: Complement and its breakdown pruducts in SLE. Rheumatalogy 44, 1227-1232 (2005).
72. Huang YF, Wang W, Han JY et al.: Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus. erythematosus patients. Eur. J. Immunogenet. 30(2), 121-124 (2003).
73. Navarra SV, Villamin CA, Baes RP et al.: Increased frequency of mannose-binding lectin promoter LX haplotype among Filipinos with systemic lupus erythematosus. Lupus 16, 147-148 (2007).
74. Ulcova-Gallova Z, Sedlacek D: Seven antiphospholipid antibodies in HIV positive patients (Abstract). Lupus 11, 569 (2002).
75. Blank M, Krause I, Fridkin M et al.: The infectious origin of the APS (Abstract). Lupus 11, 570 (2002).
76. Gharavi AE, Cox N, Romagnoli PA, Espinola RG, Harris EN, Pierangell SS: High levels of antibodies to cytomegalovirus-derived peptide are found in antiphospholipid positive sera (Abstract). Lupus 11, 569 (2002).
77. Loizou S, Singh S, Wypkema E, Asherson RA: IgG, IgM and IgA aPL in black African infectious disease patients. (Abstract). Lupus 11, 570 (2002).
78. Forastlero, RR, Martinuzzo ME, Larranaga GF: Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 14, 129-136 (2005).
79. Guillevin L, Lhote F, Cohen P et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74, 238-253 (1995).
80. Schoenfeld Y, Sherer Y, Harats D: Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 22, 293-295 (2001).
81. Wagner AD, Gerard HC, Fresemann T et al.: Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum. 43, 1543-1551 (2000).
82. Levine SM, Hellmann DB: Giant cell arteritis. Curr. Opin. Rheumatol. 14, 3-10 (2002).
83. Aggarwal A, Chag M, Sinha N, Naik S: Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int. J. Cardiol. 55. 49-55 (1997).
84. Sousa Atta MLB, Margarida PE, Leite BC, Pereira CM. Parana R, Atta AM: Autoimmune aspects of hepatitis C in Bahia. Brazil (Abstract). J. Clin. Rheum. 12, S6 (2006).
85. McMurray RW. Elbourne K: Hepatitis C virus Infection and autoimmunity. Semin. Arthritis Rheum. 26, 689-701 (1997).
86. Tepper JL, Feinman SV, D'Costa L. Sooknannan R, Pruzanski W: Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia. J. Rheumatol. 25, 925-928 (1998).
87. Ramos-Casals M, Cervera R, Yague J et al.: Cryoglobulinemia in primary Sjogren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin. Arthritis Rheum. 28, 200-205 (1998).
88. Cacoub P, Renou C. Kerr G et al.: Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum. 44. 2118-2124 (2001).
89. Monga HK, Rodriguez-Barradas MC, Breaux K et al.: Hepatitis C virus infection-related morbidity and mortality among patients with human Immunodeficiency virus infection. Clin. Infect. Dis. 33, 240-247 (2001).
90. Cacoub P, Costedat-Chalumeau N, Lidove O, Alric L: Cryoglobulinemia vasculitis. Curr. Opin. Rheumatol. 14, 29-35 (2002).
91. Guillevin L, Mahr A, Cohen P et al.: Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum. 51, 482-487 (2004).
92. Herath MG: Obstacles to Identilying viruses that cause autoimmune disease. J. Neuroimmunol. 107, 154-160 (2000).
93. Mandal K, Foteinos G, Jahangiri M, Xu Q: Role of anti-heat shock protein 60 autoantibodies in atherosclerosis. Lupus 14, 742-746 (2005).
94. Rattazzi M, Faggin E, Bertipaglia B. Pauletto P: Innate immunity and atherogenesis. Lupus 14, 747-751 (2005).